# HLA-DQA2

## Overview
HLA-DQA2 is a gene located within the major histocompatibility complex (MHC) class II region on chromosome 6, which encodes a protein involved in the immune system's antigen presentation pathway. The protein product of HLA-DQA2, known as the major histocompatibility complex, class II, DQ alpha 2, is a transmembrane protein that forms part of the MHC class II molecule. This molecule is essential for presenting extracellular antigens to CD4+ T cells, thereby playing a pivotal role in adaptive immunity. Although the HLA-DQA2 gene is considered virtually non-polymorphic and its specific protein product has not been conclusively identified, it is thought to contribute to the immune response through its interactions with other MHC class II molecules (MorzyckaWroblewska1993Structure). The gene's evolutionary conservation and its potential involvement in autoimmune diseases underscore its significance in immunogenetics (Hitman1987HLA; Dendrou2018HLA).

## Structure
HLA-DQA2 is a component of the major histocompatibility complex (MHC) class II molecules, which play a critical role in the immune response. The primary structure of HLA-DQA2 consists of amino acid sequences that form the alpha chain. This chain is integral to the protein's function and interacts with other molecules to present antigens to the immune system. The secondary structure of HLA-DQA2 includes alpha helices and beta sheets, which contribute to the protein's stability and functionality.

In terms of tertiary structure, the HLA-DQA2 protein undergoes folding to achieve a specific three-dimensional shape necessary for its biological activity. This folding is crucial for the protein's ability to interact with other molecules and perform its role in the immune response. The quaternary structure of HLA-DQA2 involves its assembly with other MHC class II molecules, typically forming a heterodimer with HLA-DQB chains. This assembly is essential for the proper presentation of antigens to T cells.

Common post-translational modifications of HLA-DQA2 include glycosylation, which can affect the protein's stability, localization, and interaction with other molecules. These modifications are important for the protein's function and regulation within the immune system.

## Function
HLA-DQA2 is a gene within the major histocompatibility complex (MHC) class II, which plays a critical role in the immune system by presenting extracellular antigens to CD4+ T cells. This antigen presentation is essential for initiating and regulating immune responses, particularly in adaptive immunity. The protein encoded by HLA-DQA2 is primarily active in antigen-presenting cells, such as dendritic cells, macrophages, and B cells, where it facilitates the recognition of foreign antigens by the immune system (Dendrou2018HLA).

The diversity of HLA molecules, including HLA-DQA2, is crucial for mounting effective immune responses against a wide range of infections. This diversity is maintained through mechanisms such as gene conversion and balancing selection, which include heterozygote advantage and frequency-dependent selection (Dendrou2018HLA). Despite its importance in immune function, the HLA-DQA2 gene is described as virtually non-polymorphic and structurally intact, with its promoter region highly conserved between different haplotypes, suggesting a high degree of evolutionary conservation (MorzyckaWroblewska1993Structure). However, the specific protein product of HLA-DQA2 has not been identified, and its precise function in healthy human cells remains unclear (MorzyckaWroblewska1993Structure).

## Clinical Significance
The HLA-DQA2 gene has been implicated in several autoimmune diseases due to its role in the immune system. Studies have shown an association between polymorphisms in the HLA-DQA2 gene and insulin-dependent diabetes mellitus (IDDM). Specifically, a TaqI restriction fragment length polymorphism (RFLP) known as 'DXaU' has been linked to IDDM, although this association is likely due to linkage disequilibrium with other HLA alleles such as DR3 and DQw8, which are known to contribute to IDDM susceptibility (Rowe1990HLADQA2). 

Research has also identified an increased frequency of the DXa genotype UU in patients with IDDM, dermatitis herpetiformis (DH), and celiac disease (CD), suggesting a genetic susceptibility encoded by the DQ-DX subregion of the HLA region (Hitman1987HLA). The association of HLA-DQA2 with these diseases highlights its potential role in genetic predisposition to autoimmune conditions. 

While the HLA-DQA2 gene itself may not directly cause these diseases, its interactions with other HLA alleles and its involvement in immune response regulation are significant factors in disease susceptibility (Hitman1987HLA).


## References


[1. (Hitman1987HLA) G A Hitman, M J Niven, H Festenstein, P G Cassell, J Awad, J Walker-Smith, J N Leonard, L Fry, P Ciclitira, and P Kumar. Hla class ii alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease. Journal of Clinical Investigation, 79(2):609–615, February 1987. URL: http://dx.doi.org/10.1172/jci112854, doi:10.1172/jci112854. This article has 82 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci112854)

[2. (Dendrou2018HLA) Calliope A. Dendrou, Jan Petersen, Jamie Rossjohn, and Lars Fugger. Hla variation and disease. Nature Reviews Immunology, 18(5):325–339, January 2018. URL: http://dx.doi.org/10.1038/nri.2017.143, doi:10.1038/nri.2017.143. This article has 528 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri.2017.143)

[3. (MorzyckaWroblewska1993Structure) Ewa Morzycka-Wroblewska, Julia I. Harwood, Jennifer R. Smith, and Martin F. Kagnoff. Structure and evolution of the promoter regions of the dqa genes. Immunogenetics, 37(5):364–372, January 1993. URL: http://dx.doi.org/10.1007/bf00216801, doi:10.1007/bf00216801. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/bf00216801)

[4. (Rowe1990HLADQA2) J.R. Rowe, M.H. Neme de Gimenez, C.A. Emler, and M.J. Sheehy. Hla-dqa2 (dx alpha) polymorphism and insulin dependent diabetes. Human Immunology, 29(4):256–262, December 1990. URL: http://dx.doi.org/10.1016/0198-8859(90)90039-r, doi:10.1016/0198-8859(90)90039-r. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/0198-8859(90)90039-r)